The pre-operative neutrophil–lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin

References

• Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. (2008). Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34:196–201.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (1995). Peritonectomy procedures. Ann Surg 221:29–42.
   PubMed Web of Science ®Google Scholar
• Miner TJ, Shia J, Jaques DP, et al. (2005). Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 241:300–8.
   PubMed Web of Science ®Google Scholar
• Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. (2007). Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 245:104–9.
   PubMed Web of Science ®Google Scholar
• Chua TC, Moran BJ, Sugarbaker PH, et al. (2012). Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–56.
   PubMed Web of Science ®Google Scholar
• Elias D, Gilly F, Quenet F, et al. (2010). Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 36:456–62.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Hutanu I, Baratti D, Deraco M. (2013). Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei. J Surg Oncol 108:1–8.
   PubMed Web of Science ®Google Scholar
• Canbay E, Ishibashi H, Sako S, et al. (2013). Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg 37:1271–6.
   PubMed Web of Science ®Google Scholar
• Chua TC, Chong CH, Liauw W, et al. (2012). Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy. Ann Surg 256:342–9.
   PubMed Web of Science ®Google Scholar
• Taflampas P, Dayal S, Chandrakumaran K, et al. (2014). Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal pseudomyxoma peritonei: analysis of 519 patients. Eur J Surg Oncol 40:515–20.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Baratti D, Hutanu I, et al. (2015). The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 41:1097–105.
   PubMed Web of Science ®Google Scholar
• Roxburgh CS, McMillan DC. (2010). Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6:149–63.
   PubMed Web of Science ®Google Scholar
• McMillan DC. (2012). The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 39:534–40.
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Mcnamara MG, Seruga B, et al. (2014). Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106:dju124.
   PubMedGoogle Scholar
• Hanahann D, Weinberg RA. (2011). Hallmarks of cancer: the next generation. Cell 144:646–74.
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–54.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang W, Feng LJ. (2014). Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis. PLoS One 9:e111906.
   PubMed Web of Science ®Google Scholar
• Cao J, Zhu X, Zhao X, et al. (2016). Neutrophil-to-lymphocyte ratio predicts PSA response and prognosis in prostate cancer: a systematic review and meta-analysis. PLoS One 11:e0158770.
   PubMed Web of Science ®Google Scholar
• Xue TC, Zhang L, Xie X, et al. (2014). Prognostic significance of the neutrophil-to-lymphocyte ratioin primary liver cancer: a meta-analysis. PLoS one 9:e96072.
   PubMed Web of Science ®Google Scholar
• Stotz M, Gerger A, Eisner F, et al. (2013). Increased neutrophil lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109:416.
   PubMed Web of Science ®Google Scholar
• Kang MH, Go SI, Song HN, et al. (2014). The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer. Br J Cancer 111:452–60.
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Nagata H, Takagi K, et al. (2013). Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer 109:401.
   PubMed Web of Science ®Google Scholar
• Di Fabio F, Mehta A, Chandrakumaran K, et al. (2016). Advanced pseudomyxoma peritonei requiring gastrectomy to achieve complete cytoreduction results in good long-term oncologic outcomes. Ann Surg Oncol 23:4316–432.
   PubMed Web of Science ®Google Scholar
• Farquharson AL, Pranesh N, Witham G, et al. (2008). A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer 99:591–6.
   PubMed Web of Science ®Google Scholar
• Tan GHC, Novo CA, Dayal S, et al. (2016). The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin. Eur J Surg Oncol 43:388–94.
   PubMed Web of Science ®Google Scholar